Related Experiment Video
Updated: Aug 24, 2026

Study of the DNA Damage Checkpoint using Xenopus Egg Extracts
Published on: November 5, 2012
Mismatch repair-mediated G2/M arrest by 6-thioguanine involves the ATR-Chk1 pathway
Kazuhiko Yamane1, Kerri Taylor, Timothy J Kinsella
1Department of Radiation Oncology, Case Western Reserve University, Case Comprehensive Cancer Center/University Hospitals of Cleveland, Cleveland, OH 44106-4942, USA.
Abstract:
DNA mismatch repair (MMR) deficiency in human cancers is associated with resistance to a spectrum of clinically active chemotherapy drugs, including 6-thioguanine (6-TG). We and others have shown that 6-TG-induced DNA mismatches result in a prolonged G2/M cell cycle arrest followed by apoptosis in MMR(+) human cancer cells, although the signaling pathways are not clearly understood. In this study, we found that prolonged (up to 4 days) treatment with 6-TG (3microM) resulted in a progressive phosphorylation of Chk1 and Chk2 in MMR(+) HeLa cells, correlating temporally with a drug-induced G2/M arrest. Transfection of HeLa cells with small interfering RNA (siRNA) against the ataxia telangiectasia-related (ATR) kinase or against the Chk1 kinase destroyed the G2/M checkpoint and enhanced the apoptosis following 6-TG treatment. On the other hand, the induction of a G2/M population by 6-TG was similar in ATM(-/-) and ATM(+) human fibroblasts, suggesting that the ATM-Chk2 pathway does not play a major role in this 6-TG response. Our results indicate that 6-TG DNA mismatches activate the ATR-Chk1 pathway in the MMR(+) cells, resulting in a G2/M checkpoint response
Insights
DNA mismatch repair (MMR) deficiency causes chemotherapy resistance. 6-thioguanine (6-TG) triggers DNA mismatches, activating the ATR-Chk1 pathway, leading to cell cycle arrest and apoptosis in MMR-proficient cancer cells.
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Background:
- DNA mismatch repair (MMR) deficiency is linked to resistance against chemotherapy drugs like 6-thioguanine (6-TG).
- 6-TG induces DNA mismatches, causing G2/M cell cycle arrest and apoptosis in MMR-proficient (MMR(+)) cancer cells, but the underlying signaling is unclear.
Purpose of the Study:
- To elucidate the signaling pathways involved in the G2/M cell cycle arrest and apoptosis induced by 6-TG in MMR(+) human cancer cells.
Main Methods:
- MMR(+) HeLa cells were treated with 6-TG (3microM) for up to 4 days.
- Phosphorylation of Chk1 and Chk2 was assessed.
- Small interfering RNA (siRNA) was used to knock down ataxia telangiectasia-related (ATR) kinase and Chk1 kinase.
- ATM(-/-) and ATM(+) human fibroblasts were used to evaluate the role of the ATM-Chk2 pathway.
Main Results:
- Prolonged 6-TG treatment led to progressive phosphorylation of Chk1 and Chk2, correlating with G2/M arrest.
- siRNA-mediated knockdown of ATR or Chk1 abolished the G2/M checkpoint and increased apoptosis.
- The ATM-Chk2 pathway did not appear to play a significant role in the 6-TG response.
Conclusions:
- 6-TG DNA mismatches activate the ATR-Chk1 pathway in MMR(+) cells.
- This activation results in a G2/M checkpoint response, contributing to the observed cell cycle arrest and apoptosis.
Related Concept Videos
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Mismatch Repair
Mismatch Repair
Restarting Stalled Replication Forks

